doi: 10.1161/hq0102.101098
© 2002 American Heart Association, Inc.
Vascular Biology |
Endothelial Dysfunction and Blood Pressure Variability in Selected Inbred Mouse Strains
From the Department of Internal Medicine (M.J.R., S.P.D., D.R.D., F.M.F., C.D.S.), Department of Pharmacology (F.M.F.), and Department of Physiology and Biophysics (C.D.S.), Cardiovascular Center, University of Iowa, Iowa City.
Correspondence to Curt D. Sigmund, PhD, Professor of Internal Medicine, 2191 Medical Laboratories, University of Iowa, Department of Internal Medicine, Iowa City, IA 52242. E-mail Curt-Sigmund{at}uiowa.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
The genetic regulation of blood pressure (BP) and endothelial function is likely to be polygenic. Because there is considerable variability in basal BP among inbred mouse strains, the purpose of this study was to determine whether a similar variability in vascular function exists among 7 "normotensive" strains. We tested the hypothesis that compared with mice with higher BPs, mice with lower BPs would have greater aortic endothelial responses to acetylcholine (ACh). Mean BP ranged from 117 to 145 mm Hg among the 7 strains. The responses of aortic rings to ACh, sodium nitroprusside, and papaverine were assessed after submaximal precontraction with prostaglandin F2
. The aortas from all strains relaxed in a concentration-dependent manner to sodium nitroprusside and papaverine, but responses to ACh were markedly impaired in the aortas, but not carotid arteries, from 129P3/J and 129X1/SvJ mice. Aortas from the other strains relaxed normally to ACh. Furthermore, the endothelium-dependent dilators ADP and A23187 caused similar relaxation in 129P3/J, 129X1/SvJ, and C57BL/6J mice. Although the data do not support the initial hypothesis, the impaired aortic response to ACh in the 129 strains is a novel finding and illustrates the potential impact that genetic background can have on vascular responsiveness.
Key Words: aorta • blood pressure • endothelium • inbred mice
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The regulation of arterial blood pressure is extremely complex and is governed by environmental and genetic factors. Because numerous genes and genetic interactions regulate blood pressure, it is difficult to truly decipher the role of any 1 gene in the control of arterial pressure. More recently, however, our ability to understand and answer complex questions related to blood pressure regulation has been aided by the advent of transgenic and gene-targeting technology, along with a continued improvement in our ability to perform physiological experiments in the mouse. Several mouse models of vascular disease and hypertension have been developed through gene-targeted deletions of endothelial NO synthase, apoE, bradykinin receptors, and atrial natriuretic peptide genes, to name a few.1–6 Transgenic mouse models of hypertension have also been developed through the overexpression of genes such as the sodium hydrogen exchanger or, from our own laboratory, the human renin and human angiotensinogen genes.7,8
Although these mouse models have proven useful to better understand some of the underlying mechanisms of hypertension and vascular disease, it is important to be aware that the genetic background of the mice used to generate these models may influence the observed phenotype. As an example, Schlager and Weibust,9 using the tail-cuff method, observed a wide range of blood pressure among 15 different inbred mouse strains. These data are particularly relevant for transgenic models of hypertension, given that the models often have a mixed genetic background consisting of genes from 129X1/SvJ and C57BL/6J mice. To date, there is limited evidence for variation in vascular function among different mouse strains, although 1 study reported that responses of cerebral arterioles to the classic endothelium-dependent vasodilator, acetylcholine (ACh), was attenuated in C57BL/6 mice compared with SV-129 (now termed 129X1/Sv) mice.10
Vascular function, or the ability for blood vessels to contract and relax in response to a variety of vasoactive substances, is an important determinant of blood pressure. Prolonged increases in pressure are often associated with impaired endothelium-dependent relaxation, which may contribute to increased risk for atherosclerotic disease and other cardiovascular events. However, it is unclear whether the blood pressure variability that exists among inbred mouse strains is associated with a similar variation in vascular function. Therefore, in the present study, we tested the hypothesis that the blood pressure of 7 inbred strains of mice, considered to be normotensive, is inversely related to endothelial function.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Animals
Seven strains of inbred mice (male) were obtained from Jackson Laboratories (Bar Harbor, Me): A/J, BALB/cJ, C57BL/6J, C3HeB/FeJ, 129P3/J, 129X1/SvJ, and SWR/J. The 129P3/J and the 129X1/SvJ strains were formerly named 129/J and 129/SVJ, respectively. The age of the mice ranged from an average of 16 to 22 weeks, and the weight ranged from 23 to 36 g. All experimental protocols were approved by the University of Iowa Animal Care and Use Committee.
Blood Pressure Measurements
The tail-cuff method (Visitech Systems BP-2000) was used to measure systolic pressure and heart rate in conscious restrained mice, as we have previously described.11 Thirty cycles of measurements were made for a period of 10 days, with the mean of the last 5 days of recordings used for the final determination of systolic blood pressure. In addition to tail-cuff recordings, indwelling carotid catheters in conscious, freely moving mice were used to record blood pressure as described previously in our laboratory.12 Mice were placed under ketamine (120 mg/kg IP) and acepromazine maleate (12 mg/kg IP) anesthesia. The right carotid artery was dissected from fat and connective tissue so that a sterile heparinized saline (50 U/mL)–filled catheter could be inserted. Catheters were tunneled subcutaneously to the back of the neck between the scapulae, exteriorized, and sutured in place. Catheters were flushed daily with heparinized saline (500 U/mL). Mean arterial pressure and heart rate were recorded 48 hours after surgery for at least 2 days.
Vascular Ring Preparation
Mice were euthanized with pentobarbital (100 mg/kg IP). Subsequently, the thoracic aorta and carotid arteries were removed and placed in Krebs buffer (in mmol/L: pH 7.4, NaCl 118.3, KCl 4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3, and glucose 11) saturated with 95% O2 and 5% CO2. Vascular rings were dissected free of loose connective and adipose tissue and cut into segments of equal length (4 aortic segments and 2 carotid segments per side). The segments were suspended in a 20 mL Krebs organ bath maintained at 37°C and connected to a force transducer for measurement of isometric tension (contraction and relaxation). Resting tension was adjusted stepwise to reach a final resting tension of 0.5 g (aorta) and 0.25 g (carotid). Our laboratory has used these methods previously.13–15
Protocols
Vessels were allowed to equilibrate for 45 minutes. The aortic and carotid vessel segments were submaximally precontracted (51% to 68% of maximum) with prostaglandin F2 (PGF2, 10 µmol/L) and the thromboxane A2 mimetic U46619 (60 nmol/L), respectively. The mean level of precontraction for each strain is listed in Table 1. When the vessels reached a stable precontracted tension, concentration-response curves to ACh, ADP, calcium ionophore (A23187), sodium nitroprusside (SNP), and papaverine (PAP, 0.01 to 10.0 µmol/L) were generated. Studies using pharmacological approaches and gene-targeted mice have shown that relaxation of the aorta and carotid arteries to ACh is mediated by endothelial NO synthase.16,17 At the end of each experiment, dose-response curves to increasing concentrations of PGF2 (aorta) and U46619 (carotid) were generated to determine the maximal contractile responses.
|
Statistical Analysis
ANOVA with repeated measures was used to test for statistically significant differences among the concentration-response curves from different mice. One-way ANOVA was used to measure for statistical differences among the blood pressure, aortic precontraction, and heart weight–to–body weight ratio data. Statistical significance was accepted at a level of P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Blood Pressure
Tail-cuff measurements were performed in restrained mice to measure systolic blood pressure and heart rate. The results demonstrate that there is a large variability in basal blood pressure among different strains, and they also support what has been previously shown by Schlager and Weibust9 (Table 2). For example, systolic pressure ranged from 114±2 mm Hg in C57BL/6J mice to 138±3 mm Hg in SWR/J mice. Despite the observation that SWR/J mice have the highest blood pressure, statistically, it is not higher than that of either 129P3/J or 129X1/SvJ mice. Although many investigators have used the tail cuff to measure systolic pressure, this method has some limitations. For example, the tail-cuff method typically underestimates blood pressure and requires increasing the mouse body temperature to increase blood flow to the tail. Therefore, we also measured arterial pressure directly through the use of indwelling carotid catheters in conscious, freely moving, tethered mice. The results obtained by this method generally agree with the tail-cuff data, with SWR/J, 129P3/J, and 129X1/SvJ mice having the highest pressures (Table 2). Statistically, the 129P3/J blood pressures were higher than those of all the other strains except SWR/J, and SWR/J pressures were higher than those of all others except 129P3/J and 129X1/SvJ. It is interesting to note the divergent blood pressure in the 2 closely related substrains of 129 mice. From these blood pressure recordings, one might expect the SWR/J and 129P3/J strains to have attenuated endothelial function compared with that of strains with statistically lower pressure.
|
The 129P3/J strain, which had one of the highest blood pressures by both methods, had a higher heart weight–to–body weight ratio than did all the other strains. The C3HeB/FeJ strain, which was in the lower blood pressure group, had a significantly lower heart weight–to–body weight ratio than did C57BL/6J, A/J, BALB/cJ, and 129P3/J strains. However, it is unclear why the heart weight–to–body weight ratio of the SWR/J strain was low compared with that of the 129P3/J strain, which had an equivalent pressure.
Vascular Function
To test whether the variability in basal blood pressure corresponds with a similar variability in vessel function, precontracted aortic rings from each strain were treated with various vasodilators. Once a stable contractile plateau was attained, the vessels were treated with various vasodilators. The responses to a maximal dose of each agonist are listed in Table 1. Concentration-response curves for each strain to ACh were generated (Figure 1). ACh produces relaxation of the aorta and carotid by activation of endothelial NO synthase, release of NO, and, ultimately, smooth muscle relaxation.4,16 Responses of the aorta to ACh were markedly impaired in the 129P3/J and 129X1/SvJ strains compared with all other strains studied (Figure 1). With the exception of the A/J strain, which had a significantly greater response to ACh compared with that of the C57BL/6J strain at lower doses, aortas from all other strains had similar responses to ACh. Two different investigators (M.J.R. and S.P.D.) independently confirmed the endothelial dysfunction observed in the 129X1/SvJ strain. The marked impairment observed in the 129P3/J and 129X1/SvJ strains was surprising. Therefore, to begin to dissect a possible mechanism, we tested 2 other endothelium-dependent agonists, ADP (receptor-mediated) and A23187 (non–receptor-mediated), in the aortas of 129P3/J, 129X1/SvJ, and C57BL/6J mice (Figure 2). The aortic responses from all 3 strains were not significantly different from each other.
|
Significantly different (P<0.05) from all other strains except 129X1/SvJ. #Significantly different (P<0.05) from all other strains except 129P3/J.
|
In addition to ACh responses in the aorta, we examined responses of the carotid arteries in C57BL/6J, 129P3/J, and 129X1/SvJ mice to determine whether the impairment to ACh seen in the aorta was present in other blood vessels (Figure 3). Surprisingly, relaxation of the carotid artery to ACh was similar (and not impaired) in the 3 strains tested. There was no significant difference in the response to 10-5 mol/L ACh in carotid arteries among C57BL/6J (86±3%, n=4), 129P3/J (71±24%, n=3), and 129X1/SvJ (69±5%, n=3) strains, measured by 1-way ANOVA. These data suggest that the impaired ACh responses were specific for the aorta.
|
Despite the evidence suggesting that the aortic dysfunction in the 129P3/J and 129X1/SvJ strains is confined to the aorta and more specifically to ACh, the possibility that the underlying smooth muscle may respond differently to dilators among the different strains still exists. Therefore, concentration-response curves to an endothelium-independent NO donor, SNP, were generated for each strain. The aortas from all strains relaxed in a concentration-dependent manner and to the same maximal level in response to SNP (Figure 4A). Relaxation of aortas in the 129P3/J strain was significantly impaired at the lower concentrations (0.1 to 3.0 µmol/L) of SNP compared with aortic relaxation in all other strains. In addition to SNP, an endothelium- and NO-independent vasodilator, PAP, was used in each strain (Figure 4B). PAP, from the benzylisoquinoline family of drugs, reportedly acts through the inhibition of calcium channels in smooth muscle to promote relaxation.18 PAP produced similar maximal vasorelaxation in all strains (by >95%). However, the aortic response to PAP was modestly impaired in the 129P3/J mice compared with BALB/cJ, C3HeB/FeJ, C57BL/6J, and SWR/J mice (at concentrations of 10-7 to 3x10-6 mol/L). Moreover, the PAP response was significantly attenuated in aortas from 129X1/SvJ mice compared with aortas from SWR/J mice at lower concentrations (0.1 to 1.0 µmol/L). Although there are some differences among strains with respect to either the SNP or PAP responses, it is clear that both agonists cause a dose-dependent relaxation of the aorta in each strain and result in similar maximal responses, suggesting that vascular muscle is intact and functioning. Importantly, the modest impairment that was observed in the 129P3/J and 129X1/SvJ strains in response to SNP or PAP was much less than that observed in these strains with ACh. However, it cannot be ruled out from the present data that this impairment to SNP or PAP may influence the ability of aortas from 129P3/J and 129X1/SvJ mice to relax to ACh.
|
Contractile responses were measured by stimulating the aorta of each mouse with increasing concentrations of PGF2 (10 to 300 µmol/L). Responses of the aorta to a submaximal concentration of PGF2 are shown in Figure 5 for each mouse strain. Maximal contraction of the aorta with U46619 (0.43 µmol/L) was also determined (data not shown). On average, 129P3/J, 129X1/SvJ, and A/J aortas contracted in response to both agents to a greater extent than did the BALB/cJ, C57BL/6J, and SWR/J aortas.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
In the present study, we report that systolic blood pressure and mean arterial blood pressure are variable among 7 different inbred mouse strains measured by the tail-cuff method and indwelling carotid artery catheters, respectively. In addition, aortic responses to ACh were different in A/J, 129P3/J, and 129X1/SvJ strains compared with responses in the other strains tested. For example, A/J mice had a more sensitive response to ACh at submaximal concentrations, whereas the 129P3/J and 129X1/SvJ aortic response to ACh was markedly attenuated at all concentrations. The impaired response to ACh observed in the aortas of the 129 strains was not present in the carotid arteries or after use of additional endothelium-dependent dilators, ADP and A23187. Aortas from all strains relaxed similarly to maximal concentrations of the endothelium-independent agonists, SNP and PAP. Although blood pressure and endothelial function varied among the mouse strains studied, an inverse relationship between blood pressure and endothelial function was not evident. For example, the aortic response to ACh was noticeably different between 129P3/J and SWR/J mice despite having mean blood pressures that were statistically the same.
Genetic Background
As the use of mouse models has become commonplace to address important physiological questions, so too has it become increasingly important to consider the genetic background of these animals when controls are selected and results are interpreted. Indeed, there have been several reports of strain-related differences among a variety of physiological characteristics.19 These phenotypic differences can be used in genetic crosses to identify genetic loci that might be important for the regulation of the desired characteristic. For example, differences between mouse strains in their susceptibility to developing gallstones20 or in their behavioral responses caused by methamphetamine21 have been used to map quantitative trait loci that contain specific genes likely to influence those specific phenotypes. More important, variability in blood pressure among different mouse strains has been used as a segregating phenotype to map loci that contain genes important for the regulation of pressure in mice.22
Understanding the importance of how genetic background mediates different phenotypes among mouse strains has become important for vascular biologists as well. For example, Paigen et al23 studied the effect of diet on aortic lesion size in various mouse strains by ranking them for susceptibility for developing atherosclerosis. C57BL/6 mice were reported to be highly susceptible, SWR mice were moderately susceptible, and 129 (129P3J) and BALB/c mice were resistant to atherosclerotic plaque formation. Still, others have shown that activation of proatherogenic genes, such as macrophage colony–stimulating factor or hemeoxygenase, by minimally modified LDL differs between inbred strains.24 These data provide further evidence of the influence of genetic background in determining physiological or pathophysiological characteristics of an animal.
Given the potential influences of genetic background on a variety of traits, it is evident that one should be aware of strain-related differences when targeted gene deletions in mice are generated, because it is very common for transgenic mice to have a mixed genetic background. For example, DNA is commonly targeted to embryonic stem cells harvested from 129 mice, which are subsequently implanted into blastocysts of C57BL/6 mice.25 The mice created from this process are often bred with C57BL/6 mice because of their greater reproductive performance. When heterozygotes are bred to generate a knockout, the genetic background becomes a random mix of 129 and C57BL/6 DNA.
Genetic Variations in Blood Pressure
In addition to our present findings, others have reported strain-related differences in blood pressure. For example, Schlager and Weibust9 have reported a wide variation in systolic blood pressure of many inbred mice by use of the tail-cuff method. To the contrary, Mattson26 reported that there were no differences in mean arterial pressure among several inbred strains but that SWR/J mice had a significantly higher systolic pressure than did other strains. The latter study used chronically implanted femoral catheters in conscious, freely moving (but tethered) mice; use of the catheters was cited as the difference between the studies. The present experiments used the tail-cuff method and indwelling carotid catheters to measure arterial blood pressure. Consistent with the report of Schlager and Weibust, we observed a wide range of blood pressure by using both methods.9 The discrepancy between our data and the data of Mattson is unclear, although age-related differences might be a factor. The average age ranged from 8 to 13 weeks in the study of Mattson and from 16 to 22 weeks in the present study.
Genetic Differences in Vascular Function
Arterial blood pressure and endothelial function have a strong inverse relationship such that hypertension is often associated with impaired endothelium-dependent relaxation. Although there is a wealth of data describing strain-related differences in the susceptibility to atherosclerosis, there is very little evidence pertaining to possible strain-related differences in endothelial function. To assess whether variability in endothelial function exists among different inbred mouse strains and whether this variability correlates with the variability in blood pressure, the aortic response to ACh was evaluated. The ACh dose-response curves show that most of the strains respond similarly to increasing concentrations of ACh, with 2 notable exceptions. First, the A/J strain, which had one of the lowest blood pressures, had a significantly greater response to ACh than did the C57BL/6J strain (also 129P3/J and 129X1/SvJ strains), particularly at lower concentrations (0.01 to 1.0 µmol/L). Second, the response to ACh in the 129P3/J (and the 129X1/SvJ) strain was markedly attenuated compared with the ACh response in all other strains. Initially, the design of these experiments included only the 129P3/J substrain of 129 inbred mice. However, in view of recent evidence that contamination of an unknown genetic background was introduced circa 1978 to the 129 strain,27,28 the authors felt it necessary to assess whether the impaired function was specific only to 129P3/J or whether it was present in other 129 substrains. Thus, the 129X1/SvJ strain was selected and found to have the same impaired response as 129P3/J to ACh. Although it is beyond the scope of the present study to examine the mechanism of all strain-related differences in endothelial function, it is important to consider potential explanations for the divergent ACh response in aortas, particularly aortas from 129P3/J and 129X1/SvJ mice.
The concentration response to ADP and A23187 for the 129P3/J, 129X1/SvJ, and C57BL/6J strains may shed some light on the potential mechanism. The results of the present study demonstrate that the aortas from all 3 of these strains respond similarly to these agonists. These data suggest that the impaired response to ACh may not be the result of global endothelial dysfunction but rather a mechanism more specific to the ACh signaling pathway in the aorta. This is further supported by the lack of impaired ACh response in the carotid arteries of the 129P3/J and 129X1/SvJ strains. However, a more global impairment of aortic function cannot be ruled out given the modest impairment of aortic segments to SNP and PAP for the 129P3/J strain and PAP for the 129X1/SvJ strain.
Finally, contractile responses of the aortas from the various inbred strains were assessed. These data are more difficult to interpret considering the wide variability in responses. Statistically, there were 2 main groups. The group with the greatest average response consisted of 129P3/J, 129X1/SvJ, and A/J mice, which had significantly greater responses than the second group, which consisted of C57BL/6J, BALB/cJ, and SWR/J mice. It is interesting to note that the 129P3/J and 129X1/SvJ strain were in the group with the highest average contraction. Not surprisingly then, the average precontraction for each individual experiment was higher for the 129P3/J and 129X1/SvJ strains than for most other strains (Table 1). This led us to consider the possibility that the impaired ACh response observed in the aortas of 129P3/J and 129X1/SvJ mice was an artifact resulting from the different levels of precontraction. However, 2 main factors argue against this. First, even though the aortas of the various strains are precontracted to different absolute tensions, aortas from all strains respond similarly to maximal doses of SNP and PAP. Second, even more telling is the fact that the aortic responses to ADP and A23187 for 129P3/J, 129X1/SvJ, and C57BL/6J strains were not different despite the statistically higher level of precontraction in the 129P3/J and 129X1/SvJ strains.
In conclusion, the present study supports the variability in blood pressure among inbred mice reported by others and demonstrates for the first time that endothelial function varies among different inbred mouse strains. However, we did not observe a correlation between the variability of endothelial function and variability of blood pressure. The striking impairment in ACh-induced relaxation in aortas from the 129 strains makes the findings considerably more intriguing, given that the 129 strains are commonly used in the process of developing gene-targeted transgenic mice. The present findings provide important (and previously unavailable) baseline data regarding vascular function in different inbred strains of mice. One should not assume that the present data are representative of the entire vasculature, given that responses of the aorta and carotid arteries were different in the 129 mice. However, because most studies of vascular function in genetically altered mice used the aorta, these data can be used as a starting point from which to design experiments and to remind investigators using transgenic and gene-targeted models that genetic background can play a crucial role in studies of vascular biology and hypertension.19 Finally, it is noteworthy to point out that the drastically different ACh responses in the 129 mouse strains may be used as a segregating phenotype in genetic crosses to ultimately identify genes important for vascular function.
|
Acknowledgments |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
This work was supported by National Institutes of Health grants HL-48058, HL-61446, HL-56006, HL-38901, NS-24621, and HL-62984 (to C.D.S. and F.M.F). Drs Ryan and Didion are recipients of Individual National Research Service Awards HL-10425 and HL-10237, respectively. We would like to thank Carl Kice Brown for his statistical expertise, data analysis, and advise.
|
Footnotes |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Consulting Editor for this article was Alan M. Fogelman, MD, Professor of Medicine and Executive Chair, Departments of Medicine and Cardiology, UCLA School of Medicine, Los Angeles, Calif.
Received August 22, 2001; accepted October 15, 2001.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Borkowski JA, Ransom RW, Seabrook GR, Trumbauer M, Chen H, Hill RG, Strader CD, Hess JF. Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem. 1995; 270: 13706–13710.
2.
Madeddu P, Milia AF, Salis MB, Gaspa L, Gross W, Lippoldt A, Emanueli C. Renovascular hypertension in bradykinin B2-receptor knockout mice. Hypertension. 1998; 32: 503–509.
3.
Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H. Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 1999; 19: 2762–2768.
4. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995; 377: 239–242.[CrossRef][Medline] [Order article via Infotrieve]
5.
Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1996; 93: 13176–13181.
6. Melo LG, Veress AT, Ackermann U, Pang SC, Flynn TG, Sonnenberg H. Chronic hypertension in ANP knockout mice: contribution of peripheral resistance. Regul Pept. 1999; 79: 109–115.[CrossRef][Medline] [Order article via Infotrieve]
7.
Kuro-o M, Hanaoka K, Hiroi Y, Noguchi T, Fujimori Y, Takewaki S, Hayasaka M, Katoh H, Miyagishi A, Nagai R, et al. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res. 1995; 76: 148–153.
8. Merrill DC, Thompson MW, Carney C, Schlager G, Robillard JE, Sigmund CD. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996; 97: 1047–1055.[Medline] [Order article via Infotrieve]
9.
Schlager G, Weibust RS. Genetic control of blood pressure in mice. Genetics. 1967; 55: 497–506.
10.
Fujii M, Hara H, Meng W, Vonsattel JP, Huang Z, Moskowitz MA. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke. 1997; 28: 1805–1810.
11. Sinn PL, Zhang X, Sigmund CD. Juxtaglomerular cell expression and partial regulation of a human renin genomic transgene driven by a minimal renin promoter. Am J Physiol. 1999; 277: F634–F642.[Medline] [Order article via Infotrieve]
12.
Davisson RL, Yang G, Beltz TG, Cassell MD, Johnson AK, Sigmund CD. The brain renin-angiotensin system contributes to the hypertension exhibited by mice containing both human renin and human angiotensinogen transgenes. Circ Res. 1998; 83: 1047–1058.
13.
Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997; 17: 2333–2340.
14. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, Faraci FM. Hyperhomocysteinemia and endothelial dysfunction in cystathionine ß-synthase-deficient mice. Am J Physiol. 2000; 279: H970–H975.
15.
Didion SP, Sigmund CD, Faraci FM. Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke. 2000; 31: 760–764.
16. Faraci FM, Sigmund CD, Shesely EG, Maeda N, Heistad DD. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998; 274: H564–H570.[Medline] [Order article via Infotrieve]
17. Lake-Bruse KD, Faraci FM, Shesely EG, Maeda N, Sigmund CD, Heistad DD. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol. 1999; 277: H770–H776.[Medline] [Order article via Infotrieve]
18.
Iguchi M, Nakajima T, Hisada T, Sugimoto T, Kurachi Y. On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea. J Pharmacol Exp Ther. 1992; 263: 194–200.
19.
Faraci FM, Sigmund CD. Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res. 1999; 85: 1214–1225.
20.
Paigen B, Schork NJ, Svenson KL, Cheah YC, Mu JL, Lammert F, Wang DQ, Bouchard G, Carey MC. Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics. 2000; 4: 59–65.
21.
Grisel JE, Belknap JK, O’Toole LA, Helms ML, Wenger CD, Crabbe JC. Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. J Neurosci. 1997; 17: 745–754.
22.
Wright FA, O’Connor DT, Roberts E, Kutey G, Berry CC, Yoneda LU, Timberlake D, Schlager G. Genome scan for blood pressure loci in mice. Hypertension. 1999; 34: 625–630.
23.
Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 1990; 10: 316–323.
24.
Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ. Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation. 2000; 102: 75–81.
25.
Sigmund CD. Viewpoint. are studies in genetically altered mice out of control? Arterioscler Thromb Vasc Biol. 2000; 20: 1425–1429.
26. Mattson DL. Comparison of arterial blood pressure in different strains of mice. Am J Hypertens. 2001; 14: 405–408.[CrossRef][Medline] [Order article via Infotrieve]
27. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet. 1997; 16: 19–27.[CrossRef][Medline] [Order article via Infotrieve]
28. Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome. 1997; 8: 390–393.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  D. W. Nuno, J. S. Harrod, and K. G. Lamping Sex-dependent differences in Rho activation contribute to contractile dysfunction in type 2 diabetic mice Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1469 - H1477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Pena-Silva, J. D. Miller, Y. Chu, and D. D. Heistad Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1354 - H1360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Modrick, S. P. Didion, C. D. Sigmund, and F. M. Faraci Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1914 - H1919. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Brown, S. P. Didion, J. J. Andresen, and F. M. Faraci Effect of Aging, MnSOD Deficiency, and Genetic Background on Endothelial Function: Evidence for MnSOD Haploinsufficiency Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1941 - 1946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ryan and G. R. McLemore Jr. Hypertension and impaired vascular function in a female mouse model of systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R736 - R742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ryan, G. R. McLemore Jr, and S. T. Hendrix Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus Hypertension, November 1, 2006; 48(5): 988 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Andresen, N. I. Shafi, W. Durante, and R. M. Bryan Jr. Effects of carbon monoxide and heme oxygenase inhibitors in cerebral vessels of rats and mice Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H223 - H230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Vincent, Y. W. Kwan, S. Lung Chan, C. Perrin-Sarrado, J. Atkinson, and J.-M. Chillon Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles Stroke, December 1, 2005; 36(12): 2691 - 2695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Didion, D. A. Kinzenbaw, and F. M. Faraci Critical Role for CuZn-Superoxide Dismutase in Preventing Angiotensin II-Induced Endothelial Dysfunction Hypertension, November 1, 2005; 46(5): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Veerareddy, C.-L. M. Cooke, P. N. Baker, and S. T. Davidge Gender differences in myogenic tone in superoxide dismutase knockout mouse: animal model of oxidative stress Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H40 - H45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ryan, S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund Angiotensin II-Induced Vascular Dysfunction Is Mediated by the AT1A Receptor in Mice Hypertension, May 1, 2004; 43(5): 1074 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ryan, S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund PPAR{gamma} Agonist Rosiglitazone Improves Vascular Function and Lowers Blood Pressure in Hypertensive Transgenic Mice Hypertension, March 1, 2004; 43(3): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Francois, K. Athirakul, L. Mao, H. Rockman, and T. M. Coffman Role for Thromboxane Receptors in Angiotensin-II-Induced Hypertension Hypertension, February 1, 2004; 43(2): 364 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kazama, G. Wang, K. Frys, J. Anrather, and C. Iadecola Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1890 - H1899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maestri, A. F. Milia, M. B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corradi, C. Emanueli, and P. Madeddu Cardiac Hypertrophy and Microvascular Deficit in Kinin B2 Receptor Knockout Mice Hypertension, May 1, 2003; 41(5): 1151 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-L. M. Cooke and S. T. Davidge Pregnancy-Induced Alterations of Vascular Function in Mouse Mesenteric and Uterine Arteries Biol Reprod, March 1, 2003; 68(3): 1072 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Didion, M. J. Ryan, L. A. Didion, P. E. Fegan, C. D. Sigmund, and F. M. Faraci Increased Superoxide and Vascular Dysfunction in CuZnSOD-Deficient Mice Circ. Res., November 15, 2002; 91(10): 938 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Didion, M. J. Ryan, G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1569 - H1576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morimoto, M. D. Cassell, and C. D. Sigmund Glia- and Neuron-specific Expression of the Renin-Angiotensin System in Brain Alters Blood Pressure, Water Intake, and Salt Preference J. Biol. Chem., August 30, 2002; 277(36): 33235 - 33241. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||